Opinion: a call for safe therapeutic and gastric interventions for adolescents and young adults with obesity and transplant-indicated leukemia - Takeaways - MDSpire

Opinion: a call for safe therapeutic and gastric interventions for adolescents and young adults with obesity and transplant-indicated leukemia

  • By

  • Miriam B. Garcia

  • Paul Perales

  • David Santos

  • Ching-Wei D. Tzeng

  • Branko Cuglievan

  • Irtiza N. Sheikh

  • May 7, 2026

  • 0 min

Share

  • 1

    Obesity in adolescents and young adults with leukemia increases treatment complications and negatively impacts survival outcomes.

  • 2

    AYA patients with obesity undergoing HSCT face higher rates of non-relapse mortality and poorer overall survival compared to those with normal weight.

  • 3

    Current literature lacks comprehensive studies on obesity management in pediatric and AYA leukemia patients requiring HSCT.

  • 4

    Practice changes at MD Anderson include normalizing chemotherapy dosing to ideal body weight to mitigate obesity-related risks.

  • 5

    The Hematopoietic Cell Transplantation-specific Comorbidity Index is utilized to assess obesity-related risks in HSCT candidates.

Original Source(s)

Related Content